CSL

CSL.AX

Tags: AU Healthcare Biotechnology

CSL Price (CSL.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

485,199,307

(0.2713)%

Market Cap of CSL (CSL.AX)

Market cap:

As of , CSL.AX has a market cap of . This makes CSL.AX the 4th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment m... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $246.5-313.55
Market Cap 120.92B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Dr. Paul F. McKenzie Ph.D.
IPO Date: June, 01, 1994
Country: AU
Currency: AUD
Headquaters: Parkville, VIC
Employees: 32698

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: